Viewing Study NCT03224351


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-02-07 @ 2:21 PM
Study NCT ID: NCT03224351
Status: COMPLETED
Last Update Posted: 2021-04-22
First Post: 2017-07-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-08-08
Start Date Type: ACTUAL
Primary Completion Date: 2018-02-28
Primary Completion Date Type: ACTUAL
Completion Date: 2018-02-28
Completion Date Type: ACTUAL
First Submit Date: 2017-07-18
First Submit QC Date: None
Study First Post Date: 2017-07-21
Study First Post Date Type: ACTUAL
Results First Submit Date: 2021-02-25
Results First Submit QC Date: None
Results First Post Date: 2021-04-22
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2021-04-22
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2021-03-29
Last Update Post Date: 2021-04-22
Last Update Post Date Type: ACTUAL